Skip to main content
 

Our Pradaxa News

Tuesday, January 14, 2014

When the U.S. Food and Drug Administration (FDA) first approved the anti-coagulant dabigatran – sold by German pharmaceutical firm Boehringer-Ingelheim (BI) under the brand name Pradaxa…

Friday, November 22, 2013

Various media sources recently announced that an experimental antidote for Pradaxa – an anticoagulant implicated in bleeding deaths – has successfully reversed the effects of the drug in healthy…

Wednesday, September 11, 2013

German pharmaceutical giant Boehringer-Ingelheim (BI) is trumpeting the news across the world: their flagship product, Pradaxa (dabigatran), approved in 100 countries around the world for stroke…

Thursday, August 1, 2013

Followers of Ring of Fire radio probably noticed a disturbing report recently about Boehringer-Ingelheim's (BI) efforts to expand the use of its anticoagulant drug, Pradaxa (dabigatran)…

Tuesday, May 14, 2013

Recently, the FDA issued a report, based in part on data from the questionable RE-LY study, stating that…

Wednesday, May 8, 2013

It's already widely-known that Boehringer-Ingelheim's anti-coagulant drug, Pradaxa, carries a high risk of patients bleeding to death – and, to add insult to injury, costs that are fifteen times…

Tuesday, March 19, 2013

These words, the first bit of advice given to space travelers in the late Douglas Adams' Hitchhiker's Guide to the Galaxy, were also issued to the medical community recently regarding the…

Wednesday, January 16, 2013

There is much to admire about modern Germany. Their citizens enjoy protections and support systems such as guaranteed health care, six weeks paid vacation every year, green energy initiatives and…

Subscribe to Pradaxa News